Evidence-Based Nutraceuticals Derived from Antrodia cinnamomea

Area of Science:

• * Mycology and Natural Product Chemistry
• * Pharmacology and Traditional Medicine

Background:

• * Antrodia cinnamomea (A. cinnamomea) is a mushroom endemic to Taiwan, traditionally used as a health tonic.
• * It contains diverse specialized metabolites, including benzenoids, polysaccharides, and triterpenoids, contributing to its bioactivity.

Purpose of the Study:

• * To review recent advancements in the cultivation, extraction, and characterization of bioactive compounds from A. cinnamomea.
• * To highlight the therapeutic potential and applications of A. cinnamomea in health supplements and functional foods.

Main Methods:

• * Review of scientific literature focusing on A. cinnamomea.
• * Emphasis on submerged and solid-state fermentation techniques for compound extraction and characterization.

Main Results:

• * Identified key bioactive compounds: benzenoids, maleic/succinic acids, ubiquinone, triterpenoids, and polysaccharides.
• * Documented pharmacological properties: antibacterial, antitumor, anti-inflammatory, hepatoprotective, hypoglycemic, antioxidant, immunomodulatory, and gut microbiota regulation.

Conclusions:

• * A. cinnamomea possesses significant therapeutic potential due to its rich bioactive compound profile.
• * Further research and evidence-based utilization can promote its application in novel therapeutic strategies and health innovations.